Purification and immunological characterization of human liver-specific F antigen

Clinica Chimica Acta; International Journal of Clinical Chemistry
Y MoriK Okuda

Abstract

Human liver specific F antigen has been purified from human liver and characterized by immunochemical and physicochemical procedures. Specific antisera were prepared by immunizing guinea pigs with the purified human F antigen. The purified F antigen had a molecular mass of approximately 80000 daltons. Using the immunodiffusion technique, it was shown that human F antigen has at least two antigenic determinants; one is species non-specific and the other human specific. This human specific determinant was also found in the liver of rhesus monkey but not in the liver of the other mammals tested. Using purified human F antigen and antibody against the human specific determinant, F antigen can be quantitated in serum and may prove to be of clinical value.

References

Jan 1, 1977·International Archives of Allergy and Applied Immunology·A A Mihas, J G Spenney
Dec 1, 1975·The Journal of Experimental Medicine·D M Silver, D P Lane
Mar 1, 1974·Archives of Internal Medicine·J B Smith, L F Barker

❮ Previous
Next ❯

Citations

Apr 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·Y MoriK Okuda
May 1, 1993·European Journal of Biochemistry·U RüetschiS Lindstedt
Jan 31, 2002·World Journal of Gastroenterology : WJG·Tao FengYu-Ping Zuo
May 1, 1991·European Journal of Immunology·J P SchofieldD B Oliveira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.